Clinical Reviews in Bone and Mineral Metabolism
Q1IF5.7SJR0.264
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.7 | Q1 | 83.0% | — | — | |
| 2024 | 2.0 | Q3 | 27.5% | — | — | |
| 2023 | 0.8 | Q4 | 16.9% | 0.264 | Q3 | 44.8% |
| 2022 | 1.8 | 22.2% | 0.503 | Q2 | 66.5% | |
| 2021 | — | 27.0% | 0.569 | Q2 | 71.2% | |
| 2020 | — | — | 0.421 | Q3 | 61.1% | |
| 2019 | — | — | 0.710 | Q2 | 77.3% | |
| 2018 | — | — | 0.336 | Q3 | 53.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1534-8644
ISSN
1559-0119
country
UScoverage
2002, 2004-2024